25. Effectiveness of High Dose Influenza Vaccine in HIV-positive Patients for the Winter 2017–2018 Season

BACKGROUND: Antibody response after high dose influenza vaccine (HDIV) approved for age ≥ 65 years, is superior to a standard-dose vaccine in HIV-infected persons. We report the effectiveness data of HDIV compared to the standard dose quadrivalent vaccine (SDIV) in our HIV clinic. METHODS: We conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Mikiro, Kunkel, Tori, Bram, David, Newman, Jessica, Lopez, Angela, Santana, Pheadra, Clough, Lisa A, Hinthorn, Daniel, El Atrouni, Wissam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776096/
http://dx.doi.org/10.1093/ofid/ofaa439.070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776096/
http://dx.doi.org/10.1093/ofid/ofaa439.070

Ejemplares similares